FDA Drug Application (020616) for KADIAN by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number020616
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameKADIAN
Active IngredientMORPHINE SULFATE



Back to FDA Applications sponsored by ALLERGAN SALES LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.